Recent advances in the treatment of acute myeloid leukemia Academic Article uri icon


MeSH Major

  • Myelodysplastic Syndromes
  • RNA-Binding Proteins


  • Acute myeloid leukemia (AML) is a disorder with significant molecular and clinical heterogeneity. Although there have been clear advances in the identification of somatic genetic and epigenetic alterations present in the malignant cells of patients with AML, translating this knowledge into an integrated view with an impact on the clinical treatment of AML has been slower to evolve. Recent clinical advances in the treatment of AML include studies demonstrating the benefit of dose-intense daunorubicin therapy in induction chemotherapy for patients of any age. We also review use of the DNA methyltransferase inhibitor azacitidine for treatment of AML in elderly patients as well as a study of global patterns of DNA methylation in patients with AML. Lastly, we review a recent assessment of the role of allogeneic hematopoietic stem cell transplantation in AML in first complete remission.

publication date

  • July 22, 2010



  • Academic Article



  • eng

PubMed Central ID

  • PMC2927833

Digital Object Identifier (DOI)

  • 10.3410/M2-55

PubMed ID

  • 20798782

Additional Document Info

start page

  • 55


  • 2


  • 1